ARTICLE | Clinical News
Cangene Corp regulatory update
December 5, 1994 8:00 AM UTC
CNJ received Australian Patent No. 647,411, covering an enhanced version of its nucleic acid sequence based amplification (NASBA) technology. NASBA detects disease and microbial contamination by targe...